Health Science Policy Council Chair 2021 - 2023

Newell McElwee

Newell McElwee, PharmD, MSPH

Pharmaceutical professional, Boehringer Ingleheim
Gwynedd Valley, PA, United States

Past Chair 2019 - 2021

Shelby Reed

Shelby Reed, RPh, PhD

Professor, Duke Clinical Research Institute
Durham, NC, United States

Chair-Elect 2023 - 2025

Maarten IJzerman

Maarten IJzerman, MSc, PhD

Dean, Professor Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia

Health Science Policy Council Members


Policy Outlook Committee

Co-Chairs

Lou Garrison, PhD

Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States

Adrian Towse, Mphil, MA

Emeritus Director, Office of Health Economics
London, United Kingdom

Members

Suliman Alghnam, MHA

Head, Population Health, KAIMRC
Riyadh, 01, Saudi Arabia

Eric Barrette

Senior Director, Health Economics, Medtronic
Washington, DC, United States

Amanda Cole, PhD, BSc

Senior Principal Economist, Office of Health Economics
London, LON, United Kingdom

Sita Ratna Devi Duddi

CEO, Dakshayani and Amaravati Health and Education
Gurugram, HR, India

Eduardo Gonzalez-Pier, PhD

Distinguished Fellow, Center for Global Development
Cuidad de Mexico, Mexico

Jens Grueger, PhD

Director and Partner, Boston Consulting Group
Freiburg, BW, Germany

Jan E. Hansen, PhD, DrPH

Vice President, Evidence for Access, Genentech
South San Francisco, CA, United States

Finn Børlum Kristensen, PhD, MD

Danish Centre for Health Economics - University of Southern Denmark
Hilleroed, 84, Denmark

Newell McElwee, PharmD, MSPH

Pharmaceutical professional, Boehringer Ingleheim
Gwynedd Valley, PA, United States

Brian O'Rourke, PharmD

President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada

Teodoro Padilla, MBA, BS

Executive Director, PHAP
Makati City, Philippines

Soualmi Redouane, MSc, PharmD

Head of Market Access & Government Affairs, Boehringer Ingelheim
Ouled Fayet, 16, Algeria

Martin Visnansky, MSc, MBA, PharmD, PhD

Senior Consultant / Lecturer, University of Veterinary Medicine and Human Pharmacy
Bratislava, Slovakia

Science/Research Committee

Co-Chairs

J. Jaime Caro, MD

Chief Scientist, Evidera
Bethesda, MD, United States

William Crown, PhD, BA, MA

Distinguished Research scientist, Brandeis University
Waltham, MA, United States

Members

Abdalla Abotaleb, MBA, PharmD, PhD, MD

World health organization (WHO)
cairo, C, Egypt

Paolo Cortesi, PhD

Assistant Professor, Research Centre on Public Health (CESP), University of Milan-Bicocca
Monza, MB, Italy

Jhony De La Cruz Vargas, MS, PhD, DrPH, MD

PRESIDENT ISPOR PERU, Universidad Ricardo Palma
Lima, LIM, Peru

Michael Drummond, PhD

Professor of Health Economics, University of York
York, YOR, United Kingdom

Stephanie Earnshaw, PhD

Senior Vice President, Health Economics, RTI Health Solutions
Pittsboro, NC, United States

Maarten IJzerman, MSc, PhD

Dean, Professor Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia

Khalid Kamal, MS, PhD

Professor and Chair, West Virginia University
Morgantown, WV, United States

Natia Kvizhinadze, PharmD

Professor, Social & Clinical Pharmacy, Tbilisi State Medical University
Tbilisi, Georgia

Vivian Lee, PharmD, BSc

Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong

Josephine Mauskopf, PhD

Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, United States

Shelby Reed, RPh, PhD

Professor, Duke Clinical Research Institute
Durham, NC, United States

Tienie Stander

VI Research
Dubai, United Arab Emirates

Ben van Hout, MSc, PhD

Scientific Director, Pharmerit International
York, United Kingdom

Hwee-Lin Wee, PhD

Associate Professor, National University of Singapore
Singapore, Singapore

Task Force Review Committee

Co-Chairs

Deborah Marshall, PhD, BSc

Professor, Arthur J.E. Child Chair, University of Calgary
Calgary, AB, Canada

Mark Sculpher, MSc, PhD, BA

Professor, University of York
York, NYK, United Kingdom

Members

Federico Augustovski, MSc, PhD, MD

Director, HTA, (IECS) Institute for Clinical Effectiveness and Health Policy
Buenos Aires, B, Argentina

Marc Berger, MD

Marc L. Berger, LLC
New York, NY, United States

Joseph Cappelleri, MS, PhD, MPH

Executive Director, Pfizer Inc
Newington, CT, United States

Reed Johnson, PhD

Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States

Daniel Malone, MS, RPh, PhD

Professor, University of Utah
Salt Lake City, UT, United States

C. Daniel Mullins, PhD

Professor, University of Maryland Baltimore
Baltimore, MD, United States

Scott Ramsey, PhD, MD

Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Seattle, WA, United States

Mark S. Roberts, MD, MPP

Professor and Chair, Health Policy and Management, University of Pittsburgh
Pittsburgh, PA, United States

Julia F. Slejko, PhD

Associate Professor, University of Maryland School of Pharmacy
Baltimore, MD, United States

Praveen Thokala, PhD, MASc

Senior Research Fellow, ScHARR, The University of Sheffield
Sheffield, United Kingdom
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×